633 related articles for article (PubMed ID: 19635028)
1. Human infections due to Streptococcus dysgalactiae subspecies equisimilis.
Brandt CM; Spellerberg B
Clin Infect Dis; 2009 Sep; 49(5):766-72. PubMed ID: 19635028
[TBL] [Abstract][Full Text] [Related]
2. Lack of mitogenic activity of speG- and speG(dys)-positive Streptococcus dysgalactiae subspecies equisimilis isolates from patients with invasive infections.
Brandt CM; Schweizer KG; Holland R; Lütticken R; Freyaldenhoven BS
Int J Med Microbiol; 2005 Dec; 295(8):539-46. PubMed ID: 16325550
[TBL] [Abstract][Full Text] [Related]
3. Characterization of fluoroquinolone-resistant beta-hemolytic Streptococcus spp. isolated in North America and Europe including the first report of fluoroquinolone-resistant Streptococcus dysgalactiae subspecies equisimilis: report from the SENTRY Antimicrobial Surveillance Program (1997-2004).
Biedenbach DJ; Toleman MA; Walsh TR; Jones RN
Diagn Microbiol Infect Dis; 2006 Jun; 55(2):119-27. PubMed ID: 16530373
[TBL] [Abstract][Full Text] [Related]
4. Distribution of virulence factors and association with emm polymorphism or isolation site among beta-hemolytic group G Streptococcus dysgalactiae subspecies equisimilis.
Lo HH; Cheng WS
APMIS; 2015 Jan; 123(1):45-52. PubMed ID: 25244428
[TBL] [Abstract][Full Text] [Related]
5. Detection of Streptococcus pyogenes virulence genes in Streptococcus dysgalactiae subsp. equisimilis from Vellore, India.
Babbar A; Itzek A; Pieper DH; Nitsche-Schmitz DP
Folia Microbiol (Praha); 2018 Sep; 63(5):581-586. PubMed ID: 29532420
[TBL] [Abstract][Full Text] [Related]
6. Correlation of virulence genes to clinical manifestations and outcome in patients with Streptococcus dysgalactiae subspecies equisimilis bacteremia.
Tsai CT; Chi CY; Ho CM; Lin PC; Chou CH; Wang JH; Wang JH; Lin HC; Tien N; Lin KH; Ho MW; Lu JJ
J Microbiol Immunol Infect; 2014 Dec; 47(6):462-8. PubMed ID: 24210866
[TBL] [Abstract][Full Text] [Related]
7. Virulence profiling of Streptococcus dysgalactiae subspecies equisimilis isolated from infected humans reveals 2 distinct genetic lineages that do not segregate with their phenotypes or propensity to cause diseases.
Davies MR; McMillan DJ; Beiko RG; Barroso V; Geffers R; Sriprakash KS; Chhatwal GS
Clin Infect Dis; 2007 Jun; 44(11):1442-54. PubMed ID: 17479940
[TBL] [Abstract][Full Text] [Related]
8. Genetic diversity and virulence properties of Streptococcus dysgalactiae subsp. equisimilis from different sources.
Gherardi G; Imperi M; Palmieri C; Magi G; Facinelli B; Baldassarri L; Pataracchia M; Creti R
J Med Microbiol; 2014 Jan; 63(Pt 1):90-98. PubMed ID: 24149625
[TBL] [Abstract][Full Text] [Related]
9. Clinical aspects of invasive infections with Streptococcus dysgalactiae ssp. equisimilis in Japan: differences with respect to Streptococcus pyogenes and Streptococcus agalactiae infections.
Takahashi T; Sunaoshi K; Sunakawa K; Fujishima S; Watanabe H; Ubukata K;
Clin Microbiol Infect; 2010 Aug; 16(8):1097-103. PubMed ID: 19732082
[TBL] [Abstract][Full Text] [Related]
10. Infections Caused by Group C and G Streptococcus (
Baracco GJ
Microbiol Spectr; 2019 Mar; 7(2):. PubMed ID: 30977463
[TBL] [Abstract][Full Text] [Related]
11. Clonal relationships between invasive and noninvasive Lancefield group C and G streptococci and emm-specific differences in invasiveness.
Pinho MD; Melo-Cristino J; Ramirez M
J Clin Microbiol; 2006 Mar; 44(3):841-6. PubMed ID: 16517864
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of emm types and antimicrobial susceptibility of Streptococcus dysgalactiae subsp. equisimilis in Austria.
Leitner E; Zollner-Schwetz I; Zarfel G; Masoud-Landgraf L; Gehrer M; Wagner-Eibel U; Grisold AJ; Feierl G
Int J Med Microbiol; 2015 Dec; 305(8):918-24. PubMed ID: 26507866
[TBL] [Abstract][Full Text] [Related]
13. Pyogenic streptococci of Lancefield groups C and G as pathogens in man.
Efstratiou A
Soc Appl Bacteriol Symp Ser; 1997; 26():72S-79S. PubMed ID: 9436319
[No Abstract] [Full Text] [Related]
14. Molecular Characterization of Invasive Streptococcus dysgalactiae subsp. equisimilis, Japan.
Wajima T; Morozumi M; Hanada S; Sunaoshi K; Chiba N; Iwata S; Ubukata K
Emerg Infect Dis; 2016 Feb; 22(2):247-54. PubMed ID: 26760778
[TBL] [Abstract][Full Text] [Related]
15. Invasive infection caused by Streptococcus dysgalactiae subsp. equisimilis: characteristics of strains and clinical features.
Takahashi T; Ubukata K; Watanabe H
J Infect Chemother; 2011 Feb; 17(1):1-10. PubMed ID: 20607346
[TBL] [Abstract][Full Text] [Related]
16. Transmission of Streptococcus dysgalactiae subsp. equisimilis between child and dog in an Aboriginal Australian community.
Schrieber L; Towers R; Muscatello G; Speare R
Zoonoses Public Health; 2014 Mar; 61(2):145-8. PubMed ID: 23745768
[TBL] [Abstract][Full Text] [Related]
17. Exploring the arthritogenicity of Streptococcus dysgalactiae subspecies equisimilis.
Oppegaard O; Mylvaganam H; Skrede S; Kittang BR
BMC Microbiol; 2018 Feb; 18(1):17. PubMed ID: 29482512
[TBL] [Abstract][Full Text] [Related]
18. Genetic Diversity in Streptococcus dysgalactiae subsp. equisimilis Isolates from Patients with Invasive and Noninvasive Infections in a Japanese University Hospital (2014-2015).
Fujita T; Horiuchi A; Ogawa M; Yoshida H; Hirose Y; Nagano N; Takahashi T
Jpn J Infect Dis; 2017 Jan; 70(1):100-104. PubMed ID: 27000456
[TBL] [Abstract][Full Text] [Related]
19. Biofilm formation of beta-hemolytic group G Streptococcus dysgalactiae subspecies equisimilis isolates and its association with emm polymorphism.
Ma JS; Chen SY; Lo HH
APMIS; 2017 Nov; 125(11):1027-1032. PubMed ID: 28885723
[TBL] [Abstract][Full Text] [Related]
20. Concomitant regulation of host tissue-destroying virulence factors and carbohydrate metabolism during invasive diseases induced by group g streptococci.
Watanabe S; Shimomura Y; Ubukata K; Kirikae T; Miyoshi-Akiyama T
J Infect Dis; 2013 Nov; 208(9):1482-93. PubMed ID: 23901096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
